Evidena Care, one of Switzerland’s leading specialised telemedicine providers for medical cannabis, has announced the launch of a nationwide online...
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend...
Astrasana Holding AG is introducing its AST-Premium Line, a new range of premium-quality cannabis flowers, to the Swiss market. The...
Switzerland has now launched its three-month public consultation on its ambitious proposals to launch a fully regulated adult-use cannabis market,...
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers,...
ATTEMPTS to decriminalise cannabis use on the British Crown Dependency of Jersey have narrowly failed. After a debate lasting almost...
Switzerland’s pioneering cannabis pilot project has developed into Europe’s most advanced and accessible adult-use framework throughout 2023. Six pilot projects...
Switzerland’s Federal Office of Public Health (FOHP) officially approved the ‘Grashaus Project’ last month, the country’s sixth adult-use cannabis pilot...
Italy’s CBD ban pushed back further by court Last week, Italy’s Regional Administrative Court of Lazio (TAR) confirmed its position,...
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis,...
Last week saw the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2000 Zurich inhabitants legal access...
Switzerland and its rapidly proliferating adult-use cannabis pilot framework is fast becoming the centre of attention for many European cannabis...
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of their...
As reported by Newsweed The Swiss city of Bern will join Basel, Zurich, Lausanne and Geneva and legally distribute...
